Jiang, N., Jiang, M., Zhu, X., Jiang, F., Ren, W., Cao, G., Chen, C., Mei, J., Li, Y., Tan, Q., Hong, Y., Guo, Z., Zhang, J., Huang, X., Zhao, Y. (2025). Tislelizumab plus short-course chemo-radiotherapy for conversion therapy of unresectable ESCC (LATE): A proof-of-concept, phase Ib trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e16119